Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor.

Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor.

Item
http://www.wikidata.org/entity/Q33750160
Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course.Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitroTumor-derived factors modulating dendritic cell function.Cancer-induced heterogeneous immunosuppressive tumor microenvironments and their personalized modulation.Prediction of therapy response in ovarian cancer: Where are we now?Novel augmentation by bufalin of protein kinase C-induced cyclooxygenase-2 and IL-8 production in human breast cancer cells.Involvement of local renin-angiotensin system in immunosuppression of tumor microenvironment.Unlocking the NF-κB Conundrum: Embracing Complexity to Achieve Specificity.Lycopene Protects Against Spontaneous Ovarian Cancer Formation in Laying Hens.Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, reduces chemokines and adhesion molecule expression induced by IL-1β in human corneal fibroblasts.Inhibition of PKC-Induced COX-2 and IL-8 Expression in Human Breast Cancer Cells by Glucosamine.Inhibition of Late and Early Phases of Cancer Metastasis by the NF-κB Inhibitor DHMEQ Derived from Microbial Bioactive Metabolite Epoxyquinomicin: A Review.
P2860

Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor.

Item
http://www.wikidata.org/entity/Q33750160
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Immunosuppression through cons ...... eversal by an NF-κB inhibitor.
@ast
Immunosuppression through cons ...... eversal by an NF-κB inhibitor.
@en
type
label
Immunosuppression through cons ...... eversal by an NF-κB inhibitor.
@ast
Immunosuppression through cons ...... eversal by an NF-κB inhibitor.
@en
prefLabel
Immunosuppression through cons ...... eversal by an NF-κB inhibitor.
@ast
Immunosuppression through cons ...... eversal by an NF-κB inhibitor.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Immunosuppression through cons ...... eversal by an NF-κB inhibitor.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P6179
P698
P921
P932